Alpha and beta estradiol protect neuronal but not native PC12 cells from paraquat-induced oxidative stress

Neurotoxicity Research

Volumn 6, Issue 2, 2004, Pages 141-148

  Gélinas, Sylvie ^a,b   Bureau, Geneviève ^a   Valastro, Barbara ^a   Massicotte, Guy ^a   Cicchetti, Francesca ^b   Chiasson, Keith ^a,b   Gagne, Benoît ^a   Blanchet, Julie ^a   Martinoli, Maria Grazia ^a,b  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Estrogens; Free radicals; Herbicide; Parkinson's disease; Rhodamine

Indexed keywords

ESTRADIOL; NEUROPROTECTIVE AGENT; PARAQUAT;

ANIMAL; ARTICLE; CELL STRAIN; COMPARATIVE STUDY; DRUG EFFECT; ISOMERISM; NERVE CELL; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; RAT;

ANIMALS; ESTRADIOL; ISOMERISM; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARAQUAT; PC12 CELLS; RATS;

EID: 4644275721     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033216     Document Type: Article

References (59)

1. + and paraquat in Rana pipiens. Life Sci. 37, 1529-1538.
2. Beal MF (2001) Experimental models of Parkinson's disease. Nat. Rev. Neurosci. 2, 325-334.
3. Behl C (2002) Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 3, 433-442.
4. Behl C, T Skutella, F Lezoualc'h, A Post, M Widmann, CJ Newton and F Holsboer (1997) Neuroprotection against oxidative stress by estrogens, structure-activity relationship. Mol. Pharmacol. 51, 535-541.
5. Betarbet R, TB Sherer and JT Greenamyre (2002) Animal models of Parkinson's disease. Bioessays 24, 308-318.
6. Bi R, G Broutman, MR Foy, RF Thompson and M Baudry (2000) The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc. Natl. Acad. Sci. USA 97, 3602-3607.
7. Birge SJ, BS McEwen and PM Wise (2001) Effects of estrogen deficiency on brain function. Implications for the treatment of postmenopausal women. Postgrad. Med. Spec No., 11-16.
8. Brooks AI, CA Chadwick, HA Gelbard, DA Cory-Slechta and HJ Federoff (1999) Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res. 823, 1-10.
9. Busciglio J, JK Andersen, HM Schipper, GM Gilad, R McCarty, F Marzatico and O Toussaint (1998) Stress, aging, and neurode-generative disorders. Molecular mechanisms. Ann. NY Acad. Sci. 851, 429-443.
10. Butterfield DA and J Kanski (2001) Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122, 945-962.
11. Cavalieri EL, K-M Li, N Balu, M Saad, P Devanesan, S Higginbothan, J Zhao, MI Gross and EG Rogan (2002a) Catechol ortho-quinones, the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis, 23, 1071-1077.
12. Cavalieri EL, ER Rogan and D Chakravarti (2002b) Initiation of cancer and other diseases by cathecol ortho-quinones, a unifying mechanism. Cell. Mol. Life Sci. 59, 665-681.
13. Chun HS, GE Gibson, LA DeGiorgio, H Zhang, VJ Kidd and JH Son (2001) Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76, 1010-1021.
14. Collins MA and EJ Neafsey (2002) Potential neurotoxic "agents provocateurs" in Parkinson's disease. Neurotoxicol. Teratol. 24, 571-577.
15. Corasaniti MT, MC Strongoli and G Nistica (1990) Determination of paraquat in rat brain using ion-pair solid-phase extraction and reversed-phase high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 527, 189-195.
16. Corasaniti MT, MC Strongoli, D Rotiroti, G Bagetta and G Nistico (1998) Paraquat, a useful tool for the in vivo study of mechanisms of neuronal cell death. Pharmacol. Toxicol. 83, 1-7.
17. Corrigan FM, L Murray, CL Wyatt and RF Shore (1998) Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease. Exp. Neurol. 150, 339-342.
18. Cyr M, F Calon, M Morissette, M Grandbois, T Di Paolo and S Callier (2000) Drugs with estrogen-like potency and brain activity, potential therapeutic application for the CNS. Curr. Pharm. Des. 6, 1287-1312.
19. Dawson T, A Mandir and M Lee (2002) Animal models of PD, pieces of the same puzzle? Neuron 35, 219-222.
20. Day BJ, M Patel, L Calavetta, LY Chang and J Stamler (1999) A mechanism of paraquat toxicity involving nitric oxide synthase. Proc. Natl. Acad. Sci. USA 96, 12760-12765.
21. Frantseva MV, PL Carlen and JL Perez Velazquez (2001) Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons. Free Radic. Biol. Med. 31, 1216-1227.
22. Garcia-Segura LM, I Azcoitia and LL DonCarlos (2001) Neuroprotection by estradiol. Prog. Neurobiol. 63, 29-60.
23. +-induced cytotoxicity in neu-ronal PC12 cells. J. Neurosci. Res. 70, 90-96.
24. Giacobini E (1998) Aging, Alzheimer's disease, and estrogen therapy. Exp. Gerontol. 33, 865-869.
25. Henderson LM and JB Chappell (1993) Dihydrorhodamine 123, a fluorescent probe for superoxide generation? Eur. J. Biochem. 217, 973-980.
26. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann. Neurol. 53 Suppl, 3, S26-S36; discussion S36-S38.
27. Kadota T, T Yamaai, Y Saito, Y Akita, S Kawashima, K Moroi, N Inagaki and K Kadota (1996) Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J. Histochem. Cytochem. 44, 989-996.
28. +) -related compounds in rat pheochromocytoma PC12 cells. Arch. Biochem. Biophys. 337, 75-80.
29. Kontakos N and J Stokes (1999) Monograph series on aging-related diseases, XII. Parkinson's disease - recent developments and new directions. Chronic Dis. Can. 20, 58-76.
30. Kooy NW, JA Royall, H Ischiropoulos and JS Beckman (1994) Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic. Biol. Med. 16, 149-156.
31. Langston JW (1998) Epidemiology versus genetics in Parkinson's disease, progress in resolving an age-old debate. Ann. Neurol. 44 (Suppl. 1), S45-S52.
32. Lee V, JQ Trojanowski and WW Schlaepfer (1982) Induction of neurofilament triplet proteins in PC12 cells by nerve growth factor. Brain Res. 238, 169-180.
33. Li X and AY Sun (1999) Paraquat induced activation of transcription factor AP-1 and apoptosis in PC12 cells. J. Neural Transm. 106, 1-21.
34. Liang X, B Lu, GK Scott, CH Chang, MA Baldwin and CC Benz (1998) Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancer. Mol. Cell. Endocrinol. 146, 151-161.
35. Liou HH, RC Chen, YF Tsai, WP Chen, YC Chang and MC Tsai (1996) Effects of paraquat on the substantia nigra of the Wistar rats, neurochemical, histological, and behavioral studies. Toxicol. Appl. Pharmacol. 137, 34-41.
36. Manning-Bog AB, AL McCormack, J Li, VN Uversky, AL Fink and DA Di Monte (2002) The herbicide paraquat causes up-regula-tion and aggregation of a-synuclein in mice, paraquat and a-synuclein. J. Biol. Chem. 277, 1641-1644.
37. Mc Cormack AL, M Thiruchelvam, AB Manning-bog, C Thiffault, JW Langston, DA Cory-Slechta and DA Di Monte (2002) Environmental risk factor and Parkinson's disease, selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol. Dis. 10, 119-127.
38. Miller MM and KB Franklin (1999) Theoretical basis for the benefit of postmenopausal estrogen substitution. Exp. Gerontol. 34, 587-604.
39. Nemery B and RJ van Klaveren (1995) NO wonder paraquat is toxic. Hum. Exp. Toxicol. 14, 308-309.
40. Nilsen J, G Mor and F Naftolin (1998) Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 5, 211-216.
41. Priyadarshi A, SA Khuder, EA Schaub and SS Priyadarshi (2001) Environmental risk factors and Parkinson's disease, a metaanaly-sis. Environ. Res. 86, 122-127.
42. Roehm NW, GH Rodgers, SM Hatfield and AL Glasebrook (1991) An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 142, 257-265.
43. Saunders-Pullman R, J Gordon-Elliott, M Parides, S Fahn, HR Saunders and S Bressman (1999) The effect of estrogen replacement on early Parkinson's disease. Neurology 52, 1417-1421.
44. Schapira AH (1998) Mitochondrial dysfunction in neurodegenera-tive disorders. Biochim. Biophys. Acta 1366, 225-233.
45. Schmuck G, E Rohrdanz, QH Tran-Thi and G Schluter (2002) Oxidative stress in rat cortical neurons and astrocytes by paraquat in vitro. Neurotoxicity Res. 4, 1-13.
46. Storch A, A Kaftan, K Burkhardt and J Schwarz (2000) 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855, 67-75.
47. Tamir S, S Izrael and J Vaya (2002) The effect of oxidative stress on ERa and ERβ expression. J. Steroid Biochem. Mol. Biol. 81, 327-332.
48. Tanner CM, R Ottman, SM Goldman, J Ellenberg, P Chan, R Mayeux and JW Langston (1999) Parkinson disease in twins, an etiologic study. J. Am. Med. Assn. 281, 341-346.
49. Thiruchelvam M, EK Richfield, RB Baggs, AW Tank and DA Cory-Slechta (2000) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb, implications for Parkinson's disease. J. Neurosci. 20, 9207-9214.
50. Thiruchelvam M, EK Richfield, BM Goodman, RB Baggs and DA Cory-Slechta (2002) Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype. Neurotoxicology 23, 621-633.
51. Toran-Allerand CD (1996) Mechanisms of estrogen action during neural development, mediation by interactions with neu-rotrophins and their receptors? J. Steroid Biochem. Mol. Biol. 56, 169-178.
52. Toran-Allerand CD, M Singh and GJ Setalo (1999) Novel mechanisms of estrogen action in the brain, new players in an old story. Front. Neuroendocrinol. 20, 97-121.
53. Vedder H, N Anthes, G Stumm, C Wurz, C Behl and JC Krieg (1999) Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J. Neurochem. 72, 2531-2538.
54. Welshons WV, ME Lieberman and J Gorski (1984) Nuclear localization of unoccupied oestrogen receptors. Nature 307, 747-749.
55. Wesseling C, B van Wendel de Joode, C Ruepert, C Leon, P Monge, H Hermosillo and TJ Partanen (2001) Paraquat in developing countries. Int. J. Occup. Environ. Health 7, 275-286.
56. Widdowson PS, MJ Farnworth, MG Simpson and EA Lock (1996) Influence of age on the passage of paraquat through the blood-brain barrier in rats, a distribution and pathological examination. Hum. Exp. Toxicol. 15, 231-236.
57. Yang W-L and AY Sun (1998a) Paraquat-induced cell death in PC12 cells. Neurochem. Res. 23, 1387-1394.
58. Yang W-L and AY Sun (1998b) Paraquat-induced free radical reaction in mouse brain microsomes. Neurochem. Res. 23, 47-53.
59. Zhang Y, VL Dawson and TM Dawson (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7, 240-250.